Interview

Body Heat to Treat Obesity

Garvan researchers have discovered a way to turn ‘energy-storing’ fat into ‘energy-burning’ fat – revealing a potentially much safer approach to treating obesity than current medication.

Dr. Yan-Chuan Shi tells Dave that in experimental models, the team targeted the Y1 receptor, which is found on fat tissues and helps store energy during starvation. They found that blocking the receptor increased body heat generation and reduced weight gain by 40%.

Obesity is a major public health issue which affects a third of Australian adults. Most current obesity medication targets appetite in the brain, which can have severe psychiatric and cardiovascular side effects and has seen many drugs withdrawn from the market.

This new therapy approach has the potential to be a safer approach, targeting obesity in the fat tissue directly.

Y1 receptor linked to obesity

Obesity and overweight are major public health issues, which in Australia are estimated to affect two thirds of all adults. The condition can lead to severe medical complications, including diabetes, cardiovascular disease and some cancers, and while lifestyle changes are essential to weight loss, medication is a crucial adjunct treatment option for some.

The authors of the study investigated Y1 receptors controlled by the molecule NPY, which is released in the body under conditions of starvation to help reduce energy expenditure and increase fat storage.

Surprisingly, the team discovered that Y1 receptors were produced at higher levels in the fat tissue of obese individuals.

The team then blocked the Y1 receptor using the experimental treatment BIBO3304 in a mouse model of obesity.

“In our study, we found that mice that were administered BIBO3304 and fed a high-fat diet gained about 40% less body weight over seven weeks than mice on a high-fat diet alone. This significant reduction of body weight gain was caused by an increase in body heat generation and reduction in fat mass,” says Dr Shi.

“Further, when we applied BIBO3304 to human fat cells isolated from obese individuals, we found that the cells began switching on the same genes involved in producing heat as the ones in mice, which suggests that targeting the Y1 receptor pathway may similarly increase fat metabolism and reduce weight gain in humans,” Dr Shi adds.

Targeting obesity at the source

“NPY is a metabolism regulator that plays a critical role during states of low energy supply, where it helps store fat as a survival mechanism. Today however, these advantageous effects can exacerbate existing diet-induced weight gain, leading to obesity and metabolic disease,” says co-senior author Professor Herbert Herzog, Head of the Eating Disorders Lab at Garvan.

The researchers say a crucial component of the study was to demonstrate that the experimental treatment BIBO3304 did not cross the blood brain barrier, and that the anti-obesity effects of blocking the Y1 receptor pathways occurred not via the brain, but specifically only in peripheral tissues.

“Most current prescribed treatments are aimed at reducing food intake by targeting the central nervous system. However, these can have significant psychiatric or cardiovascular side effects, which have resulted in over 80% of these medications being withdrawn from the market,” says Dr Shi.

“Our study is crucial evidence that blocking Y1 receptors in peripheral tissues without affecting the central nervous system is effective at preventing obesity by increasing energy expenditure. It reveals a new therapeutic approach that is potentially safer than current medications that target appetite,” says Professor Herzog.

“Our team and other groups have revealed further potential benefits in targeting the NPY-Y1 receptor system, including the stimulation of bone cell growth, and improvement in cardiovascular function and insulin resistance,” he adds. “We hope that the publication of our findings will lead to increased interest for exploring BIBO3304 and related agents as potential treatments for obesity and other health conditions.”

Other Articles You May Like

Entertainment and Arts

Are The Female Fanbase Key to Taylor Swift’s Success?

By: Laura Bennett Love it or hate it, Taylor Swift...

February 23, 2024
News

Sustaining Hope in the Midst of Conflict: Pray for Ukraine

By: Joni BoydFebruary 24 marks two years since Russia declared...

February 23, 2024
Faith

The Disturbing Contradiction at the Heart of Secular Morality

By: Akos Balogh There’s a contradiction built into the heart...

February 22, 2024
News

Kylie & Dannii Minogue Headline New Bluey Book Reads Series

By: Justin Rouillon BBC Studios Kids & Family and Brisbane’s...

February 22, 2024